Passion for Health
삼성바이오에피스는 더 많은 환자들에게 고품질의 바이오의약품을 합리적인 가격으로 사용할 수 있는 기회를 제공하기 위해 최선을 다하고 있습니다.
News & Stories
삼성바이오에피스의 최신 소식과 이야기를 만나보세요.
NEWS
Apr 10, 2025
Apr 8, 2025
Apr 6, 2025
Mar 19, 2025
Mar 14, 2025
Feb 28, 2025
Gain insights into the price and cost of commercially available biosimilars in the US, as well as price and market share trends since their launch.
Apr 24, 2025
We’re turning up the green. From harnessing solar power to improving energy efficiency, we're making steady progress toward a cleaner, more sustainable future.
Apr 22, 2025
Did you know? Bleeding disorders are blood disorders, but not all blood disorders are bleeding disorders.
Apr 17, 2025
In our new Biosimilars Explained series, we're breaking down key biosimilar terms, beginning with the cornerstone of it all: the reference product.
Apr 15, 2025
Today in Biosimilars: Europe's first biosimilar approval paved the way for its global leadership in biosimilar adoption. Discover more in this series as we exp...
Apr 11, 2025
At IMKASID 2025 in Seoul, Samsung Bioepis shared how switching to biosimilars can unlock major cost savings for payers and patients across Europe.
LINKEDIN
The first quarter of 2025 brought significant shifts in market competition and regulatory dynamics in the US.
On this World Hemophilia Day, we recognize not only hemophilia but also other bleeding and blood disorders that impact millions of people worldwide.
In our new Biosimilars Explained series, we're breaking down key biosimilar terms, beginning with the cornerstone of it all: the referenc
Today in Biosimilars: Europe's first biosimilar approval paved the way for its global leadership in biosimilar adoption
At IMKASID 2025 in Seoul, Samsung Bioepis shared how switching to biosimilars can unlock major cost savings across Europe. Our findings highlight biosimilars’ ...
Join Us
삼성바이오에피스는 미래를 이끌어갈 인재를 기다리고 있습니다.
오늘 하루 그만보기 닫기
삼성바이오에피스 홈페이지에서 당사 소셜미디어 사이트로 이동하시겠습니까?